The Centers for Disease Control and Prevention's (CDC’s) newly reworked Advisory Committee on Immunization Practices (ACIP) ...
A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). | A trio of ...
The latest untitled letter from the FDA’s Office of Prescription Drug Promotion zeroes in on a patient testimonial video ...
One day after the FDA’s new director of the Center for Drug Evaluation and Research (CDER), Richard Pazdur, M.D., informed ...
Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from ...
The Buckland Group launched Quvara Medical as the newest CDMO to debut this year after buying a former Becton Dickinson manufacturing site in the U.K. for an undisclosed price. | The Buckland Group ...
After many months of uncertainty related to the Biosecure Act and associated security efforts in Washington, D.C., Chinese ...
Cosmo Pharmaceuticals has revealed topline results from two phase 3 trials which indicate that its topical cream clascoterone ...
Daiichi Sankyo has emerged victorious in appeals court, flipping a prior multimillion-dollar patent verdict on its head and ...
The overlap between the work of J&J and Watts has led to a joint push to get women over 40 to focus on eye health. Together, ...
The phase 3 comeback story Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. | ...
Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. | Excelsior Sciences, which spun out of investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results